Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma

40 patients with advanced non-small cell lung cancer not previously treated were included in a study at phase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 each 28 days for 6 cycles. There were 31 men and 9 women, being the average age of 5...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Richardet, Eduardo Arnoldo, Carranza, L., Uribe, A., Tolocka, H., Cresta, Cecilia, Uribe, E., Uribe, M.
Formato: Artículo
Lenguaje:Español
Publicado: 1995
Materias:
R Medicina (General)
Acceso en línea:http://pa.bibdigital.ucc.edu.ar/3717/1/A_Richardet_Carranza_Uribe_Tolocka_Cresta_Uribe_Uribe.pdf
Aporte de:
Producción Académica Universidad Católica de Córdoba (UCCor) de Universidad Católica de Córdoba
id I38-R144-3717
record_format dspace
spelling I38-R144-37172025-04-11T22:22:10Z http://pa.bibdigital.ucc.edu.ar/3717/ Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma Richardet, Eduardo Arnoldo Carranza, L. Uribe, A. Tolocka, H. Cresta, Cecilia Uribe, E. Uribe, M. R Medicina (General) 40 patients with advanced non-small cell lung cancer not previously treated were included in a study at phase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 each 28 days for 6 cycles. There were 31 men and 9 women, being the average age of 54 years, with "performance Status" grade 0-2. All of them could be evaluated for toxicity and 31 for responsiveness. 10 patients were in stage IIIb and 21 at stage IV. 42% of objective responses were obtained and an overall survival of 9 months, which justifies further studies. 1995-12-31 info:eu-repo/semantics/article info:eu-repo/semantics/closedAccess application/pdf spa http://pa.bibdigital.ucc.edu.ar/3717/1/A_Richardet_Carranza_Uribe_Tolocka_Cresta_Uribe_Uribe.pdf Richardet, Eduardo Arnoldo, Carranza, L., Uribe, A., Tolocka, H., Cresta, Cecilia, Uribe, E. and Uribe, M. (1995) Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma. Revista de la Facultad de Ciencias Médicas (Córdoba, Argentina), 53 (1). pp. 27-32. ISSN 0014-6722
institution Universidad Católica de Córdoba
institution_str I-38
repository_str R-144
collection Producción Académica Universidad Católica de Córdoba (UCCor)
language Español
orig_language_str_mv spa
topic R Medicina (General)
spellingShingle R Medicina (General)
Richardet, Eduardo Arnoldo
Carranza, L.
Uribe, A.
Tolocka, H.
Cresta, Cecilia
Uribe, E.
Uribe, M.
Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
topic_facet R Medicina (General)
description 40 patients with advanced non-small cell lung cancer not previously treated were included in a study at phase II with vinorelbine 20 mg/Sq.m days 1 and 8, etoposide 60 mg/sq.m days 1-3 and cisplatin 75 mg/sq.m day 1 each 28 days for 6 cycles. There were 31 men and 9 women, being the average age of 54 years, with "performance Status" grade 0-2. All of them could be evaluated for toxicity and 31 for responsiveness. 10 patients were in stage IIIb and 21 at stage IV. 42% of objective responses were obtained and an overall survival of 9 months, which justifies further studies.
format Artículo
author Richardet, Eduardo Arnoldo
Carranza, L.
Uribe, A.
Tolocka, H.
Cresta, Cecilia
Uribe, E.
Uribe, M.
author_facet Richardet, Eduardo Arnoldo
Carranza, L.
Uribe, A.
Tolocka, H.
Cresta, Cecilia
Uribe, E.
Uribe, M.
author_sort Richardet, Eduardo Arnoldo
title Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
title_short Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
title_full Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
title_fullStr Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
title_full_unstemmed Phase II trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
title_sort phase ii trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma
publishDate 1995
url http://pa.bibdigital.ucc.edu.ar/3717/1/A_Richardet_Carranza_Uribe_Tolocka_Cresta_Uribe_Uribe.pdf
work_keys_str_mv AT richardeteduardoarnoldo phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT carranzal phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT uribea phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT tolockah phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT crestacecilia phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT uribee phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
AT uribem phaseiitrialwithnavelbinecisplatinetoposideinthetreatmentofinoperablenonsmallcelllungcarcinoma
_version_ 1832592361465577472

Ejemplares similares